Morning traders 11 / 12, page-64

  1. Goblin
    72,146 Posts.
    lightbulb Created with Sketch. 140
    clock Created with Sketch.
    11/12/17
    10:45
    Post #: 29529797
    PAB

    Melbourne, Australia; December 11, 2017: Patrys Limited (ASX: PAB), a therapeutic antibody development company, is pleased to announce that pre-clinical experiments with Patrys’ therapeutic candidate PAT-DX1 confirm that it acts synergistically with olaparib, the first approved PARP (poly (ADP-ribose) polymerase) inhibitor.
    Likes Created with Sketch. 1  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EMR Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau
right-arrow Created with Sketch.
TLG Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year
right-arrow Created with Sketch.
NEWS Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch
right-arrow Created with Sketch.
EBR EBR reaches review milestone for wireless cardiac pacing device
right-arrow Created with Sketch.
NEWS Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip
right-arrow Created with Sketch.
NEWS Government spend has to stop or interest rates must rise, property expert
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.